IFNG and neoplasm: Although EVax strongly inhibited tumor growth, as expected, the EVax anti‐tumor response was eliminated in mice treated with anti‐IFN‐γ (Figure 3H), indicating that IFN‐γ plays a critical role in the EVax‐mediated anti‐tumor response.